|
http://www.aarkstore.com/categories/index.asp ARCA biopharma, Inc. – Product Pipeline Review – H2 2011 Summary Global Market Direct pharmaceuticals report, “ARCA biopharma, Inc. - Product Pipeline Review - H2 2011” provides data on the ARCA biopharma, Inc. research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from Global Markets Direct proprietary databases, ARCA biopharma, Inc. corporate website, SEC filings, investor presentations and featured press releases, both from ARCA biopharma, Inc. and industry-specific third party sources, put together by Global Markets Direct team. Scope - ARCA biopharma, Inc. - Brief ARCA biopharma, Inc. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of ARCA biopharma, Inc. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of ARCA biopharma, Inc. with complete description of the product developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the ARCA biopharma, Inc. pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Reasons to buy - Evaluate ARCA biopharma, Inc. strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of ARCA biopharma, Inc. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the ARCA biopharma, Inc. R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas. - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with ARCA biopharma, Inc.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of ARCA biopharma, Inc. and identify potential opportunities in those areas. For more information, please visit :- Marketing Team Aarkstore Enterprise Phone:08149852585 Email:enquiry@aarkstore.com URL:www.aarkstore.com http://twitter.com/aarkstoredotcom http://in.linkedin.com/in/aarkstore http://www.facebook.com/aarkstoreenterprise http://www.aarkstore.com/reports/ARCA-biopharma-Inc-Product-Pipeline-Review-H2-2011-161743.html More Related Reports :- http://www.aarkstore.com/search/viewresults.asp?search=Product%20Pipeline%20Review%20&PubId=&pagenum=1 Zealand Pharma A/S – Product Pipeline Review – H2 2011 Back Pain - Pipeline Review, H2 2011 Allergopharma Joachim Ganzer KG – Product Pipeline Review – H2 2011 Antyra, Inc. – Product Pipeline Review – H2 2011 Hyperparathyroidism - Pipeline Review, H2 2011 ARCA biopharma, Inc. – Product Pipeline Review – H2 2011 Polycystic Kidney Disease - Pipeline Review, H2 2011 Genetic Immunity, LLC – Product Pipeline Review – H2 2011
Related Articles -
ARCA, biopharma, Inc, Product, Pipeline, Review, Market research reports, Market growth, Market size, Market trends, Market forecasts, Market analysis,
|
